Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAU-7b (fenretinide) in Long COVID with moderate to severe symptoms
NCT05999435Phase 3Completed
- Sponsor
- Laurent Pharma
- Start
- Nov 2023
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fenretinide in post-acute sequelae of SARS-CoV-2 infection (PASC), sponsored by Laurent Pharma. Started Nov 2023; status: completed.
02
Drugs
fenretinide
03
Conditions
post-acute sequelae of SARS-CoV-2 infection (PASC)
Beyond the preview
Go deeper on NCT05999435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05999435.